Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume – What’s Next?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBYGet Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 3,648,237 shares changed hands during trading, an increase of 554% from the previous session’s volume of 558,130 shares.The stock last traded at $6.89 and had previously closed at $6.87.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Check Out Our Latest Research Report on Coloplast A/S

Coloplast A/S Stock Performance

The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The stock has a market cap of $15.55 billion, a P/E ratio of 25.56, a price-to-earnings-growth ratio of 0.67 and a beta of 0.33. The firm’s 50-day moving average is $7.55 and its two-hundred day moving average is $8.46.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last posted its earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. As a group, research analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.

About Coloplast A/S

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

Read More

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.